BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

How Z-DNA/RNA binding proteins shape homeostasis, inflammation, and immunity

  • Kim, Chun (Department of Molecular and Life Science, Hanyang University [ERICA Campus])
  • Received : 2020.06.22
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The right-handed double-helical structure of DNA (B-DNA), which follows the Watson-Crick model, is the canonical form of DNA existing in normal physiological settings. Even though an alternative left-handed structure of DNA (Z-DNA) was discovered in the late 1970s, Z-form nucleic acid has not received much attention from biologists, because it is extremely unstable under physiological conditions, has an ill-defined mechanism of its formation, and has obscure biological functions. The debate about the physiological relevance of Z-DNA was settled only after a class of proteins was found to potentially recognize the Z-form architecture of DNA. Interestingly, these Z-DNA binding proteins can bind not only the left-handed form of DNA but also the equivalent structure of RNA (Z-RNA). The Z-DNA/RNA binding proteins present from viruses to humans function as important regulators of biological processes. In particular, the proteins ADAR1 and ZBP1 are currently being extensively re-evaluated in the field to understand potential roles of the noncanonical Z-conformation of nucleic acids in host immune responses and human disease. Despite a growing body of evidence supporting the biological importance of Z-DNA/RNA, there remain many unanswered principal questions, such as when Z-form nucleic acids arise and how they signal to downstream pathways. Understanding Z-DNA/RNA and the sensors in different pathophysiological conditions will widen our view on the regulation of immune responses and open a new door of opportunity to develop novel types of immunomodulatory therapeutic possibilities.

Keywords

References

  1. Wang AH, Quigley GJ, Kolpak FJ et al (1979) Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature 282, 680-686 https://doi.org/10.1038/282680a0
  2. Drew H, Takano T, Tanaka S, Itakura K and Dickerson RE (1980) High-salt d(CpGpCpG), a left-handed Z' DNA double helix. Nature 286, 567-573 https://doi.org/10.1038/286567a0
  3. Herbert A, Lowenhaupt K, Spitzner J and Rich A (1995) Chicken double-stranded RNA adenosine deaminase has apparent specificity for Z-DNA. Proc Natl Acad Sci U S A 92, 7550-7554 https://doi.org/10.1073/pnas.92.16.7550
  4. Berger I, Winston W, Manoharan R et al (1998) Spectroscopic characterization of a DNA-binding domain, Z alpha, from the editing enzyme, dsRNA adenosine deaminase: evidence for left-handed Z-DNA in the Z alpha-DNA complex. Biochemistry 37, 13313-13321 https://doi.org/10.1021/bi9813126
  5. Schwartz T, Rould MA, Lowenhaupt K, Herbert A and Rich A (1999) Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 284, 1841-1845 https://doi.org/10.1126/science.284.5421.1841
  6. Placido D, Brown BA 2nd, Lowenhaupt K, Rich A and Athanasiadis A (2007) A left-handed RNA double helix bound by the Z alpha domain of the RNA-editing enzyme ADAR1. Structure 15, 395-404 https://doi.org/10.1016/j.str.2007.03.001
  7. Brown BA 2nd, Lowenhaupt K, Wilbert CM, Hanlon EB and Rich A (2000) The zalpha domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA. Proc Natl Acad Sci U S A 97, 13532-13536 https://doi.org/10.1073/pnas.240464097
  8. Schwartz T, Behlke J, Lowenhaupt K, Heinemann U and Rich A (2001) Structure of the DLM-1-Z-DNA complex reveals a conserved family of Z-DNA-binding proteins. Nat Struct Biol 8, 761-765 https://doi.org/10.1038/nsb0901-761
  9. Rothenburg S, Deigendesch N, Dittmar K et al (2005) A PKR-like eukaryotic initiation factor 2alpha kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains. Proc Natl Acad Sci U S A 102, 1602-1607 https://doi.org/10.1073/pnas.0408714102
  10. Kim YG, Muralinath M, Brandt T et al (2003) A role for Z-DNA binding in vaccinia virus pathogenesis. Proc Natl Acad Sci U S A 100, 6974-6979 https://doi.org/10.1073/pnas.0431131100
  11. Koehler H, Cotsmire S, Langland J et al (2017) Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3. Proc Natl Acad Sci U S A 114, 11506-11511 https://doi.org/10.1073/pnas.1700999114
  12. Kim U, Garner TL, Sanford T, Speicher D, Murray JM and Nishikura K (1994) Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J Biol Chem 269, 13480-13489 https://doi.org/10.1016/S0021-9258(17)36857-6
  13. O'Connell MA, Krause S, Higuchi M et al (1995) Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 15, 1389-1397 https://doi.org/10.1128/MCB.15.3.1389
  14. Patterson JB and Samuel CE (1995) Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 15, 5376-5388 https://doi.org/10.1128/MCB.15.10.5376
  15. Poulsen H, Nilsson J, Damgaard CK, Egebjerg J and Kjems J (2001) CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol Cell Biol 21, 7862-7871 https://doi.org/10.1128/MCB.21.22.7862-7871.2001
  16. Strehblow A, Hallegger M and Jantsch MF (2002) Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol Biol Cell 13, 3822-3835 https://doi.org/10.1091/mbc.E02-03-0161
  17. Gallo A, Vukic D, Michalik D, O'Connell MA and Keegan LP (2017) ADAR RNA editing in human disease; more to it than meets the I. Hum Genet 136, 1265-1278 https://doi.org/10.1007/s00439-017-1837-0
  18. Athanasiadis A, Placido D, Maas S, Brown BA 2nd, Lowenhaupt K and Rich A (2005) The crystal structure of the Zbeta domain of the RNA-editing enzyme ADAR1 reveals distinct conserved surfaces among Z-domains. J Mol Biol 351, 496-507 https://doi.org/10.1016/j.jmb.2005.06.028
  19. Chung H, Calis JJA, Wu X et al (2018) Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell 172, 811-824.e14 https://doi.org/10.1016/j.cell.2017.12.038
  20. Rice GI, Kasher PR, Forte GM et al (2012) Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 44, 1243-1248 https://doi.org/10.1038/ng.2414
  21. Wang Q, Khillan J, Gadue P and Nishikura K (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290, 1765-1768 https://doi.org/10.1126/science.290.5497.1765
  22. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M and Seeburg PH (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279, 4894-4902 https://doi.org/10.1074/jbc.M311347200
  23. Wang Q, Miyakoda M, Yang W et al (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279, 4952-4961 https://doi.org/10.1074/jbc.M310162200
  24. Liddicoat BJ, Piskol R, Chalk AM et al (2015) RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115-1120 https://doi.org/10.1126/science.aac7049
  25. Mannion NM, Greenwood SM, Young R et al (2014) The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9, 1482-1494 https://doi.org/10.1016/j.celrep.2014.10.041
  26. Suzuki N, Suzuki T, Inagaki K et al (2005) Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. J Invest Dermatol 124, 1186-1192 https://doi.org/10.1111/j.0022-202X.2005.23732.x
  27. Koeris M, Funke L, Shrestha J, Rich A and Maas S (2005) Modulation of ADAR1 editing activity by Z-RNA in vitro. Nucleic Acids Res 33, 5362-5370 https://doi.org/10.1093/nar/gki849
  28. Ng SK, Weissbach R, Ronson GE and Scadden AD (2013) Proteins that contain a functional Z-DNA-binding domain localize to cytoplasmic stress granules. Nucleic Acids Res 41, 9786-9799 https://doi.org/10.1093/nar/gkt750
  29. Protter DS and Parker R (2016) Principles and Properties of Stress Granules. Trends Cell Biol 26, 668-679 https://doi.org/10.1016/j.tcb.2016.05.004
  30. Herbert A (2019) Z-DNA and Z-RNA in human disease. Commun Biol 2, 7 https://doi.org/10.1038/s42003-018-0237-x
  31. Fu Y, Comella N, Tognazzi K, Brown LF, Dvorak HF and Kocher O (1999) Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene 240, 157-163 https://doi.org/10.1016/S0378-1119(99)00419-9
  32. Takaoka A, Wang Z, Choi MK et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501-505 https://doi.org/10.1038/nature06013
  33. Ishii KJ, Kawagoe T, Koyama S et al (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451, 725-729 https://doi.org/10.1038/nature06537
  34. Lippmann J, Rothenburg S, Deigendesch N et al (2008) IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol 10, 2579-2588 https://doi.org/10.1111/j.1462-5822.2008.01232.x
  35. Kuriakose T and Kanneganti TD (2018) ZBP1: Innate Sensor Regulating Cell Death and Inflammation. Trends Immunol 39, 123-134 https://doi.org/10.1016/j.it.2017.11.002
  36. Pasparakis M and Vandenabeele P (2015) Necroptosis and its role in inflammation. Nature 517, 311-320 https://doi.org/10.1038/nature14191
  37. Kaiser WJ, Upton JW and Mocarski ES (2008) Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol 181, 6427-6434 https://doi.org/10.4049/jimmunol.181.9.6427
  38. Rebsamen M, Heinz LX, Meylan E et al (2009) DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10, 916-922 https://doi.org/10.1038/embor.2009.109
  39. Upton JW, Kaiser WJ and Mocarski ES (2012) DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290-297 https://doi.org/10.1016/j.chom.2012.01.016
  40. Pham TH, Kwon KM, Kim YE, Kim KK and Ahn JH (2013) DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1. J Virol 87, 3076-3086 https://doi.org/10.1128/JVI.02860-12
  41. Kuriakose T, Man SM, Malireddi RK et al (2016) ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol 1, aag2045 https://doi.org/10.1126/sciimmunol.aag2045
  42. Thapa RJ, Ingram JP, Ragan KB et al (2016) DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host Microbe 20, 674-681 https://doi.org/10.1016/j.chom.2016.09.014
  43. Maelfait J, Liverpool L, Bridgeman A, Ragan KB, Upton JW and Rehwinkel J (2017) Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis. EMBO J 36, 2529-2543 https://doi.org/10.15252/embj.201796476
  44. Lin J, Kumari S, Kim C et al (2016) RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540, 124-128 https://doi.org/10.1038/nature20558
  45. Newton K, Wickliffe KE, Maltzman A et al (2016) RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129-133 https://doi.org/10.1038/nature20559
  46. Schoggins JW, MacDuff DA, Imanaka N et al (2014) Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691-695 https://doi.org/10.1038/nature12862
  47. Daniels BP, Kofman SB, Smith JR et al (2019) The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons. Immunity 50, 64-76 e64 https://doi.org/10.1016/j.immuni.2018.11.017
  48. Lladser A, Mougiakakos D, Tufvesson H et al (2011) DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther 19, 594-601 https://doi.org/10.1038/mt.2010.268
  49. Hirvinen M, Capasso C, Guse K et al (2016) Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Mol Ther Oncolytics 3, 16002 https://doi.org/10.1038/mto.2016.2
  50. Jiao H, Wachsmuth L, Kumari S et al (2020) Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature 580, 391-395 https://doi.org/10.1038/s41586-020-2129-8
  51. Wang R, Li H, Wu J et al (2020) Gut stem cell necroptosis by genome instability triggers bowel inflammation. Nature 580, 386-390 https://doi.org/10.1038/s41586-020-2127-x
  52. Marshall PR, Zhao Q, Li X et al (2020) Dynamic regulation of Z-DNA in the mouse prefrontal cortex by the RNAediting enzyme Adar1 is required for fear extinction. Nat Neurosci 23, 718-729 https://doi.org/10.1038/s41593-020-0627-5